GlaxoSmithKline Pharmaceuticals board to consider un-audited financial results

01 Jul 2016 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on July 28, 2016, to consider and approve Un-Audited Financial Results for the first quarter ended June 30, 2016 (Q1).

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

1993.05 -4.55 (-0.23%)
14-May-2024 14:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1543.90
Dr. Reddys Lab 5894.90
Cipla 1369.85
Zydus Lifesciences 981.10
Lupin 1641.45
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.